Kordata Dynamics Raises Pre-seed Round

Kordata Dynamics, a Bakersfield, California-based clinical trial innovation company, has emerged from stealth with a pre-seed funding round to support the launch of its AI-powered platform for precision clinical trials. The company, a spin-out from BIOS Health, aims to address inefficiencies in clinical research by providing technology to simplify the capture, processing, and interpretation of health data.

Investors

Participants in the round include MAVRK Celestia Fund, Kern Venture Group, and Digital Neural Infrastructure Holdings.

Kordata Dynamics Use of Funds

Kordata Dynamics intends to use the capital to scale its AI-powered clinical trial model, expand its network of hospital and clinical sites starting in Bakersfield, and deploy its technology to support precision neuromodulation and neural therapies.

About Kordata Dynamics

Founded as a spin-out of BIOS Health, Kordata Dynamics is led by CEO Emil Hewage and President Dawn McCollough. The company focuses on making precision medicine more accessible by leveraging real-time clinical trial execution technology and proprietary AI biomarker technology to improve the speed, quality, and accessibility of medical research.

Funding Details

Company Website: https://kordatadynamics.com

Company: Kordata Dynamics
Round: Pre-seed
Funding Date: May 21, 2026
Additional Investors: MAVRK Celestia Fund, Kern Venture Group, Digital Neural Infrastructure Holdings
Company Website: kordatadynamics.com
Software Category: Healthtech
Source: https://www.businesswire.com/news/home/20260518839043/en/Kordata-Dynamics-Emerges-From-Stealth-With-Launch-of-AI-Platform-for-Next-Generation-Precision-Clinical-Trials-and-Backing-From-BIOS-Health-Investors